CAS: 91526-18-0; 4-(Hydroxymethyl)-5-Methyl-1,3-Dioxol-2-One

相似化合物

37830-90-3 80715-22-6 80841-78-7

上下游产品

4-formyloxymethyl-5-methyl-1,3-dioxolen-2-one 4-bromomethyl-1,3-dioxa-5-methylcyclopentene-2-one 4,5-Dimethyl-1,3-dioxole-2-one 4-chloromethyl-5-methyl-1,3-dioxol-2-one (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate Azilsartan medoxomil benzyl 1-{[((5-methyl-2-oxo-[1,3]dioxol-4-en-4-yl)methoxy)carbonyl]-aminomethyl}-1-cyclohexane-acetate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate

4,5-二甲基-1,3-二氧杂环戊烯-2-酮置于selenium(Iv) Oxide体系中,用 1,4-二氧六环 作为反应溶剂,化学反应生成 4-(羟基甲基)-5-甲基-[1,3]二氧代l-2-酮
参考文献:Purine Inhibitors Of Fructose 1,6-Bisphosphatase
标题:Purine Inhibitors Of Fructose 1,6-Bisphosphatase
摘要:描述了具有以下结构的新型嘌呤化合物及其作为果糖-1,6-二磷酸酶抑制剂的用途.其中a从以下组中选择:-nr82,-nhso2R3,-or5,-sr5,卤素,低碳烷基,-con(R4)2,胍基,酰胍基,-h和全氟烷基;e从以下组中选择:-h,卤素,低硫代烷基,低全氟烷基,低碳烷基,低烯烃基,低炔烃基,低烷氧基,-cn和-nr72;x从以下组中选择:-烷基-Nr-,烷基,烯基,炔基,芳基,杂环芳基,-烷基-Nr-烷基-,-烷基-O-烷基-,-烷基-S-烷基-,-烷基-S-,脂环烯,杂环脂环,1,1-二卤代烷基,-c(O)-烷基-,-nr-c(O)-nr'-,-烷基-Nr-c(O)-,-烷基-C(O)-nr-,-ar-烷基-和-烷基-Ar-,所有这些都可以是可选的取代基,其中每个r和r'都是独立选择的-h和低碳烷基,每个"烷基"和"芳基"分别是独立选择的烷基或芳基;y从以下组中选择:-h,烷基,烯基,炔基,芳基,脂环,杂环脂环,芳基烷基,芳氧基烷基,烷氧基烷基,-c(O)R3,-s(O)2R3,-c(O)-or3,-conhr3,-nr22和-or3,除h外都可以是可选的取代基;以及其药学上可接受的前药和盐.

专利信息

专利号:CN-1618797-A
优先权日:2003-11-21
标题:New synthesis process of prisasin

专利号:US-7199106-B2
优先权日:2003-06-17
标题 :Lincomycin derivatives possessing antimicrobial activity
发明人：LEWIS JASON G; ANANDAN SAMPATH-KUMAR; O'DOWD HARDWIN; GORDEEV MIKHAIL F
权利人:VICURON PHARM INC
摘要:Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.